ENZN

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Enzon Pharmaceuticals (ENZN) Ownership - Who owns Enzon Pharmaceuticals?

Enzon Pharmaceuticals Inc is positioned as a public company acquisition vehicle, where the Company can become an acquisition platform and more fully utilize its net operating loss carryforwards and enhance stockholder value... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

20 Commerce Drive

Phone

+1 732 980-4500

Employees

Web

http://www.enzon.com

Details

Group

Domestic Stock Funds

Fundamentals

ENZN

Capitalization

6.68M

P/E Ratio

96.10

Risk (Beta)

0.42

Dividend Yield

N/A

Total Cash

46.9M

Total Cash/Share

0.63

Total Debt

116M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.00%

Revenue

26K

ROE

N/A

Book Value

3.01M

P/B Ratio

2.22

Cash Flow

N/A

Earnings

-0.01

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

742K

Current Ratio

28.10

Current Revenue Per Employee

6775000.00

Dividends Per Share - Security

0.00

EBITDA

-1.33M

Float

N/A

Float - Current

N/A

Gross Income Margin

100.00

Revenue To Assets

-1.05

Shares Held By Institutions

1.54K

Shares Outstanding - Current

74.2M

Total Liabilities

44.2M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-42.345

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of innovative therapeutics for cancer patients

Industry Biotechnology